Alternate Title: Office of the Biomedical Advanced Research and Development Authority Strategic Plan 2011-2016
Taken from the Office of the Biomedical Advanced Research and Development Authority Strategic Plan: "Within the last ten years, the United States has experienced an intentional attack with a biological agent in the form of the anthrax letters as well as naturally emerging outbreaks of high-consequence infectious diseases, including pandemic influenza and SARS. These events represented national security threats and public health emergencies. The past decade has also witnessed the dramatic spread of antimicrobial resistance and community outbreaks of multidrug-resistant bacteria that had previously been confined to hospitals. Concerns persist about the potential use of chemical, biological, radiological and nuclear agents by terrorists. Effective medical countermeasures such as vaccines, antimicrobials, therapeutics, and diagnostics have the potential to reduce the impact of such threats and are a bulwark of our national defense and public health emergency preparedness. The mission of the Biomedical Advanced Research and Development Authority (BARDA) is to develop and procure medical countermeasures that address the public health and medical consequences of chemical, biological, radiological, and nuclear (CBRN) accidents, incidents and attacks, pandemic influenza, and emerging infectious diseases."
|Publisher:||United States. Office of the Biomedical Advanced Research and Development Authority|
|Series:||National Public Health Strategy|
|Retrieved From:||Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response: http://www.phe.gov|